Johannes C. M. Keltjens

Senior Advisor at INKEF Capital BV

Johannes C. M. Keltjens

Johannes C. M. Keltjens

Senior Advisor at INKEF Capital BV

Career Highlights

JenaValve Technology, Inc.
JenaValve Technology GmbH
Sapiens Steering Brain Stimulation BV

RelSci Relationships


Number of Boards






RelSci Relationships are individuals Johannes C. M. Keltjens likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at JenaValve Technology GmbH

Relationship likelihood: Strong

Founder at JenaValve Technology, Inc.

Relationship likelihood: Strong

Partner, Life Sciences at Andera Partners SCA

Relationship likelihood: Strong

Chief Executive Officer at Syncona Investment Management Ltd.

Relationship likelihood: Strong

Partner, Health & Care at Gimv NV

Relationship likelihood: Strong

Chief Executive Officer at JenaValve Technology GmbH

Relationship likelihood: Strong

Former Chief Executive Officer, Founder at Axonics Modulation Technologies, Inc.

Relationship likelihood: Strong

General Partner at Forbion Capital Partners Management Holding BV

Relationship likelihood: Strong

Managing Partner at Wellington Partners GmbH

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Neoss Ltd.

Relationship likelihood: Strong

Paths to Johannes C. M. Keltjens
Potential Connections via
Relationship Science
Johannes C. M. Keltjens
Senior Advisor at INKEF Capital BV
BS Physics

The vast majority of education is undergraduate education provided by the departments to students, who are adults with no other academic qualifications than a secondary education diploma. Some education is also provided to members of the postgraduate designer programs, but they are employed by the university and do not count as part of the student body. Undergraduate education was given in four- or five-year programs until 2002. Starting in 2002, following the entry into force of the Bologna Accords, the university switched to the bachelor/master structure. The undergraduate programs are now split into two programs each, a three-year bachelor program and a two-year master program. These programs are completely independent, in the sense that a bachelor can leave the university with his title and go to work, can enter a master's program at another university or continue on to the master's program of his department at the university. And bachelors from other universities can also enroll in the new master's programs.

Career History
Senior Advisor

INKEF Capital’s mission is to invest in the Netherlands in companies with the potential to develop new technologies into commercially successful products and markets. They aim to generate returns that are commensurate with the high risk and long term character of these investments. In this endeavor, they build upon the long term investment perspective of ABP, INKEF Capital's cornerstone LP.

2013 - Current

Syncona Partners LLP provides financial resources to individuals and companies. It operates as an investment company, taking an active role in identifying, supporting and developing technologies with the potential to significantly impact the healthcare market of the future. The firm focus on healthcare companies with defendable technology or transformational business models and can invest at any stage. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Executive Chairman & Interim Chief Executive Officer
2015 - Prior

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

Boards & Committees
Chairman, Supervisory Board
2016 - Current

NightBalance BV develops and markets sensor-devices for the treatment of sleep apnea. It offers sleep position trainer, a small and light aid which can be worn around the chest with an ergonomic band. The firm's a sleep position sensor which gradually and comfortably trains patients using vibrations to not sleep on their back. The company was founded by Eline van Beest and Thijs van Oorschot in 2009 and is headquartered in The Hague, the Netherlands.

Member, Board of Directors
2013 - Current

Syncona Partners is an active manager invests early transactions. The firm in which they invests include life science innovation.

Chairman, Board of Directors

ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Johannes C. M. Keltjens. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Johannes C. M. Keltjens's profile does not indicate a business or promotional relationship of any kind between RelSci and Johannes C. M. Keltjens.